SEC Form 4 · accession 0001209191-15-036753
SYNAPTICS Inc · SYNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Deutsch
Officer — SVP of Sales
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000817720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 27, 2015 | S | 1,603 | $85.0864 | D | 7,534 | D | |
| Common StockF3 | Apr 27, 2015 | S | 200 | $85.835 | D | 7,334 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $85.69 | Apr 24, 2015 | A | 4,075 | A | — | Apr 24, 2022 | Common Stock | 4,075 | 4,075 | D |
Explanation of responses
- F1The shares were sold pursuant to a 10b5-1 Sales Plan dated February 20, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.62 to $85.61, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.64 to $86.03, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F41/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018.